ADA Scientific Sessions 2025 Abstract

Revolutionary GLP-1 Weight Loss Medicine Semaglutide—To Cover or Not to Cover?

By Wenhao Lu, Amelia Xie, Yimei You

Computational studyBiomarkers

The paper

Wenhao Lu, Amelia Xie, Yimei You

Short Hills

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 1050-P

doi.org/10.2337/db25-1050-p

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity